PURPOSE: The goal of this study was to evaluate a difference in HRQOL and ISCL results between men and women with Asthma.
METHODS: The 65 patients (39 women, age: 58,2 and 26 men, age: 54,8) diagnosed with bronchial asthma and treated at the Department of Allergology, Wroclaw Medical University, Poland in 2009-2010 entered the study. We validated questionnaire to assess the patient’s overall health perception the SF-36 Health Survey. As a comparator for asthma control level we have used the Asthma Control Test (ACT).
RESULTS: The results of ACT did not reveal any statistical differences between men and woman and men tested: 12,3;(SD)5,5 vs. 14,9 (SD)5,4; p>0,05. Significant differences were observed in HRQOL as measured by SF-35 questionnaire, however. In all domains women had worse results than men: (PF): 36,9, (SD) 31,2 vs. 51,2 (SD)34,5; (RP):20,5, (SD)33,4 vs. 43,3, (SD) 42,8; (BP): 49,8, (SD) 28,8 vs.52,8, (SD) 31,9; (GH): 34,0,(SD)19,7 vs. 34,8, (SD) ±14,1; (VT):39,2,(SD)22,8 vs. 52,7, (SD) 22,8; (SF): 48,5,(SD) 33,6 vs. 52,6,(SD) 28,1; (RE):40,2, (SD)42,7 vs. 56,4,(SD) 40,9 and (MH): 49,6, (SD) 23,4 vs. 65,6, (SD) 21,0. Also in overall physical and mental health status women reported worse quality of life than men -physical component summary (PCS): 36,7,(SD)22,1 vs. 50,0,(SD)29,0 respectively and mental component summary (MCS):43,2, (SD) 22 vs. 52,3,(SD)20,4, respectively. Conclusions: Although disease control (ACT) was similar in male and female patients, women reported significantly worse HRQOL as measured by SF- 36 in all eight domains. We therefore conclude that gender is an independent factor which influence quality of life in asthmatic patients.
CONCLUSIONS: Although disease control (ACT) was similar in male and female patients, women reported significantly worse HRQOL as measured by SF- 36 in all eight domains. We therefore conclude that gender is an independent factor which influence quality of life in asthmatic patients
CLINICAL IMPLICATIONS: It is important to include gender differences to improve medical treatment, patient' s quality of life and compliance.
DISCLOSURE: The following authors have nothing to disclose: Andrzej Fal, Izabella Uchmanowicz, Beata Jankowska-Polanska, Bernard Panaszek, Bartosz Uchmanowicz
No Product/Research Disclosure Information